本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kura Oncology, Inc

8.45
+0.02000.24%
成交量:41.39萬
成交額:350.03萬
市值:7.46億
市盈率:-2.66
高:8.60
開:8.45
低:8.40
收:8.43
52周最高:12.49
52周最低:5.41
股本:8,832.98萬
流通股本:6,398.56萬
量比:1.42
換手率:0.65%
股息:- -
股息率:- -
每股收益(TTM):-3.1784
每股收益(LYR):-3.1784
淨資產收益率:-94.82%
總資產收益率:-25.33%
市淨率:4.29
市盈率(LYR):-2.66

資料載入中...

2026/03/05

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/05

重要事件披露

Form 8-K - Current report
2026/01/29

重要事件披露

Form 8-K - Current report
2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report
2025/12/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

重要事件披露

Form 8-K - Current report
2025/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/13

重要事件披露

Form 8-K - Current report
2025/11/04

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans